Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Dulaglutide

GLP-1 Therapy: The Role of IL-6 Signaling and Adipose Tissue Remodeling in Metabolic Response

Company n/r · Phase 4 · Completed · Enrollment 23

NCT04387201

ArmPopulationDoseWeeksEstimandWeight change
Cyanocobalamin, then DulaglutideObesity or overweightn/r6n/rn/r
Dulaglutide, then CyanocobalaminObesity or overweightn/r6n/rn/r